Protease-activated receptor-2 is essential for factor VIIa and Xa-induced signaling, migration, and invasion of breast cancer cells

被引:180
作者
Morris, DR
Ding, Y
Ricks, TK
Gullapalli, A
Wolfe, BL
Trejo, J
机构
[1] Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27599 USA
[2] Univ N Carolina, Dept Cell & Dev Biol, Lineberger Comprehens Canc Ctr, Sch Med, Chapel Hill, NC 27599 USA
关键词
D O I
10.1158/0008-5472.CAN-05-1735
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Protease-activated receptors (PAR) are G protein-coupled receptors that function as cell-surface sensors for coagulant proteases, as well as other proteases associated with the tumor microenvironment. PAR1 is activated by thrombin whereas the upstream coagulant protease Vila bound to tissue factor and Xa can activate both PAR1 and PAR2. PAR1 has been implicated in tumor cell growth, migration, and invasion whereas the function of PAR2 in these processes is largely unknown. Towards defining the functional importance of PAR2 in cancer cells, we used small interfering RNAs to deplete highly invasive breast cancer cells of endogenous PAR proteins. Our findings strongly suggest that PAR2 is critical for MDA-MB-231 and BT549 breast cancer cell migration and invasion towards NIH 3T3 fibroblast conditioned medium. To define the relative importance of PAR1 versus PAR2 in mediating factor Vila and Xa responses, we assessed signaling in cancer cells lacking either endogenous PAR1 or PAR2 proteins. Strikingly, in MDA-MB-231 cells depleted of PAR2, we observed a marked inhibition of VIIa and Xa signaling to phosphoinositide hydrolysis and extracellular signal-regulated kinase 1/2 activation whereas signaling by VIIa and Xa remained intact in PAR1-deficient cells. Factor VIIa and Xa-induced cellular migration was also impaired in MDA-MB-231 cells deficient in PAR2 but not in cells lacking PAR1. Together, these studies reveal the novel findings that. PAR2, a second protease-activated G protein-coupled receptor, has a critical role in breast cancer cell migration and invasion and functions as the endogenous receptor for coagulant proteases VIIa and Xa in these cells.
引用
收藏
页码:307 / 314
页数:8
相关论文
共 35 条
  • [1] ALBINI A, 1987, CANCER RES, V47, P3239
  • [2] Malignancies, prothrombotic mutations, and the risk of venous thrombosis
    Blom, JW
    Doggen, CJM
    Osanto, S
    Rosendaal, FR
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 293 (06): : 715 - 722
  • [3] Bohm SK, 1996, J BIOL CHEM, V271, P22003
  • [4] PAR1 is a matrix metalloprotease-1 receptor that promotes invasion and tumorigenesis of breast cancer cells
    Boire, A
    Covic, L
    Agarwal, A
    Jacques, S
    Sherifl, S
    Kuliopulos, A
    [J]. CELL, 2005, 120 (03) : 303 - 313
  • [5] Persistent signaling by dysregulated thrombin receptor trafficking promotes breast carcinoma cell invasion
    Booden, MA
    Eckert, LB
    Der, CJ
    Trejo, J
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 2004, 24 (05) : 1990 - 1999
  • [6] Tissue factor- and factor X-dependent activation of protease-activated receptor 2 by factor VIIa
    Camerer, E
    Huang, W
    Coughlin, SR
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (10) : 5255 - 5260
  • [7] Platelets, protease-activated receptors, and fibrinogen in hematogenous metastasis
    Camerer, E
    Qazi, AA
    Duong, DN
    Cornelissen, I
    Advincula, R
    Coughlin, SR
    [J]. BLOOD, 2004, 104 (02) : 397 - 401
  • [8] Genetic evidence that protease-activated receptors mediate factor Xa signaling in endothelial cells
    Camerer, E
    Kataoka, H
    Kahn, M
    Lease, K
    Coughlin, SR
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (18) : 16081 - 16087
  • [9] Differential expression of protease-activated receptors-1 and-2 in stromal fibroblasts of normal, benign, and malignant human tissues
    D'Andrea, MR
    Derian, CK
    Santulli, RJ
    Andrade-Gordon, P
    [J]. AMERICAN JOURNAL OF PATHOLOGY, 2001, 158 (06) : 2031 - 2041
  • [10] β-Arrestin-dependent endocytosis of proteinase-activated receptor 2 is required for intracellular targeting of activated ERK1/2
    DeFea, KA
    Zalevsky, J
    Thoma, MS
    Déry, O
    Mullins, RD
    Bunnett, NW
    [J]. JOURNAL OF CELL BIOLOGY, 2000, 148 (06) : 1267 - 1281